Unknown

Dataset Information

0

In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy


ABSTRACT:

Background

ABCB11 variations are responsible for a spectrum of rare liver diseases, including progressive familial intrahepatic cholestasis type 2 (PFIC2) and intrahepatic cholestasis of pregnancy (ICP). Current medical treatment of these conditions mostly relies on ursodeoxycholic acid with limited efficacy. We report on the in vitro study of the p.A257V missense variant of ABCB11 identified in a PFIC2 patient and in her mother who experienced ICP.

Results

The Ala257 residue is located outside the ATP-binding site of ABCB11. We show that the p.A257V variant of ABCB11 is correctly expressed at the canalicular membrane of HepG2 cells but that its function significantly decreased when studied in MDCK cells. This functional defect can be fully rescued by Ivacaftor.

Conclusion

Ivacaftor could be considered as a new pharmacological tool able to respond to an unmet medical need for patients with ICP and PFIC2 due to ABCB11 variations affecting ABCB11 function, even when the residue involved is not located in an ATP-binding site of ABCB11.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13023-021-02125-4.

SUBMITTER: Mareux E 

PROVIDER: S-EPMC8600881 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5603585 | biostudies-literature
| S-EPMC4873882 | biostudies-literature
| S-EPMC3940180 | biostudies-literature
| S-EPMC6155230 | biostudies-literature
| S-EPMC4989713 | biostudies-literature
| S-EPMC7389072 | biostudies-literature
| S-EPMC6333085 | biostudies-literature
| S-EPMC8454405 | biostudies-literature
2013-04-18 | E-GEOD-46157 | biostudies-arrayexpress
| S-EPMC4121405 | biostudies-literature